BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 17618115)

  • 1. Mycophenolic acid as a latent agonist of PPARgamma.
    Ubukata M; Takamori H; Ohashi M; Mitsuhashi S; Yamashita K; Asada T; Nakajima N; Matsuura N; Tsuruga M; Taki K; Magae J
    Bioorg Med Chem Lett; 2007 Sep; 17(17):4767-70. PubMed ID: 17618115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor gamma agonists inhibit adipocyte expression of alpha1-acid glycoprotein.
    Castriota G; Thompson GM; Lin Y; Scherer PE; Moller DE; Berger JP
    Cell Biol Int; 2007 Jun; 31(6):586-91. PubMed ID: 17240171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 2-cyano-lup-1-en-3-oxo-20-oic acid, a cyano derivative of betulinic acid, activates peroxisome proliferator-activated receptor gamma in colon and pancreatic cancer cells.
    Chintharlapalli S; Papineni S; Liu S; Jutooru I; Chadalapaka G; Cho SD; Murthy RS; You Y; Safe S
    Carcinogenesis; 2007 Nov; 28(11):2337-46. PubMed ID: 17724373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaempferol and quercetin isolated from Euonymus alatus improve glucose uptake of 3T3-L1 cells without adipogenesis activity.
    Fang XK; Gao J; Zhu DN
    Life Sci; 2008 Mar; 82(11-12):615-22. PubMed ID: 18262572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, biological evaluation, and molecular modeling investigation of new chiral fibrates with PPARalpha and PPARgamma agonist activity.
    Pinelli A; Godio C; Laghezza A; Mitro N; Fracchiolla G; Tortorella V; Lavecchia A; Novellino E; Fruchart JC; Staels B; Crestani M; Loiodice F
    J Med Chem; 2005 Aug; 48(17):5509-19. PubMed ID: 16107150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships for inhibition of inosine monophosphate dehydrogenase and differentiation induction of K562 cells among the mycophenolic acid derivatives.
    Mitsuhashi S; Takenaka J; Iwamori K; Nakajima N; Ubukata M
    Bioorg Med Chem; 2010 Nov; 18(22):8106-11. PubMed ID: 20934342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
    Choi SS; Cha BY; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
    Life Sci; 2009 Jun; 84(25-26):908-14. PubMed ID: 19376135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of the transactivation activity of phenylpropanoic acid-type peroxisome proliferator-activated receptor pan agonists: effect of introduction of fluorine at the linker part.
    Kasuga J; Oyama T; Hirakawa Y; Makishima M; Morikawa K; Hashimoto Y; Miyachi H
    Bioorg Med Chem Lett; 2008 Aug; 18(16):4525-8. PubMed ID: 18662876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Luteolin inhibits adipogenic differentiation by regulating PPARgamma activation.
    Park HS; Kim SH; Kim YS; Ryu SY; Hwang JT; Yang HJ; Kim GH; Kwon DY; Kim MS
    Biofactors; 2009; 35(4):373-9. PubMed ID: 19353690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-dependent vascular actions of cannabidiol in the rat aorta.
    O'Sullivan SE; Sun Y; Bennett AJ; Randall MD; Kendall DA
    Eur J Pharmacol; 2009 Jun; 612(1-3):61-8. PubMed ID: 19285060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxisome proliferator-activated receptor gamma transactivation-mediated potentiation of glucose uptake by Bai-Hu-Tang.
    Chen CC; Hsiang CY; Chiang AN; Lo HY; Li CI
    J Ethnopharmacol; 2008 Jun; 118(1):46-50. PubMed ID: 18440169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Caspase-mediated degradation of PPARgamma proteins in adipocytes.
    He F; Doucet JA; Stephens JM
    Obesity (Silver Spring); 2008 Aug; 16(8):1735-41. PubMed ID: 18497737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based drug design of a novel family of PPARgamma partial agonists: virtual screening, X-ray crystallography, and in vitro/in vivo biological activities.
    Lu IL; Huang CF; Peng YH; Lin YT; Hsieh HP; Chen CT; Lien TW; Lee HJ; Mahindroo N; Prakash E; Yueh A; Chen HY; Goparaju CM; Chen X; Liao CC; Chao YS; Hsu JT; Wu SY
    J Med Chem; 2006 May; 49(9):2703-12. PubMed ID: 16640330
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Berberine increases expression of GATA-2 and GATA-3 during inhibition of adipocyte differentiation.
    Hu Y; Davies GE
    Phytomedicine; 2009 Sep; 16(9):864-73. PubMed ID: 19403287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin exerts antidifferentiation effect through AMPKalpha-PPAR-gamma in 3T3-L1 adipocytes and antiproliferatory effect through AMPKalpha-COX-2 in cancer cells.
    Lee YK; Lee WS; Hwang JT; Kwon DY; Surh YJ; Park OJ
    J Agric Food Chem; 2009 Jan; 57(1):305-10. PubMed ID: 19093868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhodanine derivatives as novel peroxisome proliferator-activated receptor gamma agonists.
    Liu Q; Zhang YY; Lu HL; Li QY; Zhou CH; Wang MW
    Acta Pharmacol Sin; 2007 Dec; 28(12):2033-9. PubMed ID: 18031620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolic acid induces adipocyte-like differentiation and reversal of malignancy of breast cancer cells partly through PPARĪ³.
    Zheng ZH; Yang Y; Lu XH; Zhang H; Shui XX; Liu C; He XB; Jiang Q; Zhao BH; Si SY
    Eur J Pharmacol; 2011 May; 658(1):1-8. PubMed ID: 21349264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAR-5359, a well-balanced PPARalpha/gamma dual agonist, exhibits equivalent antidiabetic and hypolipidemic activities in vitro and in vivo.
    Kim MK; Chae YN; Son MH; Kim SH; Kim JK; Moon HS; Park CS; Bae MH; Kim E; Han T; Choi HH; Shin YA; Ahn BN; Lee CH; Lim JI; Shin CY
    Eur J Pharmacol; 2008 Oct; 595(1-3):119-25. PubMed ID: 18727927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
    Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
    Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PAR-1622 is a selective peroxisome proliferator-activated receptor gamma partial activator with preserved antidiabetic efficacy and broader safety profile for fluid retention.
    Kim MK; Chae YN; Kim HS; Choi SH; Son MH; Kim SH; Kim JK; Moon HS; Park SK; Shin YA; Kim JG; Lee CH; Lim JI; Shin CY
    Arch Pharm Res; 2009 May; 32(5):721-7. PubMed ID: 19471887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.